sites of action in coagulation system novel factor xa and dt inhibitors

26

Upload: senta

Post on 06-Feb-2016

28 views

Category:

Documents


0 download

DESCRIPTION

Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors. Brief Overview of NOACs. NOACs Important Comparative Features. Effect on NOAC Plasma Levels from D-D Interactions, and Recommendations. Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 2: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 3: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Sites of Action in Coagulation System

Novel Factor Xa and DT Inhibitors

Page 4: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Brief Overview of NOACs

Page 5: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

NOACsImportant Comparative Features

Page 6: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 7: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Effect on NOAC Plasma Levels from D-D Interactions, and Recommendations

Page 8: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 9: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Sites of Action in Coagulation System

Novel Factor Xa and DT Inhibitors

Page 10: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Brief Overview of NOACs

Page 11: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Ethnic Differences in Rate of ICH

Page 12: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Estimated Levels of Exposurein White and Japanese Patients

Page 13: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 14: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 15: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Primary Efficacy End Point (Stroke/SEE) mITT Population While on Treatment

Page 16: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Main Safety ResultsSafety Cohort on Treatment

Page 17: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors
Page 18: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Lower NOAC DoseClinical Implications

Page 19: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Incidence of Stroke or Systemic Embolism

Page 20: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Abbreviations

Page 21: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Abbreviations (cont)

Page 22: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

Abbreviations (cont)

Page 23: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

References

Page 24: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

References (cont)

Page 25: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

References (cont)

Page 26: Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors

References (cont)